PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
13-Feb-2024 Stuttering Therapeutics Market Poised for Remarkable 14% CAGR Growth Through 2033 MARKITWIRED
13-Feb-2024 Radiotherapy Induced Oral Mucositis Treatment Market Foresees Notable US$4.89 Billion Valuation in 2033 MARKITWIRED
13-Feb-2024 Global High-End Cellomics Market will achieve a valuation of US$ 639.2 Million by 2033 | FMI MARKITWIRED
13-Feb-2024 Lupus Nephritis Treatment Market Charts Course for Significant US$5.67 Billion Valuation by 2033 MARKITWIRED
13-Feb-2024 Global Opioid Analgesics Market is on track for significant growth, with forecasting an upswing to US$ 72.0 Billion by 2033 | FMI Analysts MARKITWIRED
13-Feb-2024 Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Market Foresees Noteworthy US$4.89 Billion Valuation by 2033 MARKITWIRED
13-Feb-2024 Global Cold Laser Therapy Market is poised to hit US$ 180.8 Million by 2033, growing at a CAGR of 4.4% | FMI MARKITWIRED
13-Feb-2024 Arthralgia Management Market Aims for a Staggering US$15.5 Billion Valuation by 2033 MARKITWIRED
13-Feb-2024 Global Replacement Sheets Market with expectations set at US$ 198.42 million by 2033, driven by a 4.5% CAGR | FMI MARKITWIRED
13-Feb-2024 Global Home Infusion Therapy Devices Market Poised for Significant Growth, Reaching US$ 4.4 Billion by 2033, with a 6.6% CAGR as per FMI MARKITWIRED
13-Feb-2024 Global Infection Prevention Market is set to grow at a 3.1% CAGR, reaching US$ 55,379.1 million by 2034 | FMI MARKITWIRED
13-Feb-2024 Global Advance Wound Care Industry is poised to achieve US$ 14,667.7 million by 2034, with a CAGR of 2.4% | FMI MARKITWIRED
13-Feb-2024 Otsuka Announces Phase 3 Topline Results of AVP-786 in the Treatment of Agitation Associated With Dementia Due to Alzheimer’s Disease Businesswire
13-Feb-2024 Oragenics, Inc. Announces Leadership Transition Businesswire
13-Feb-2024 AHF Rolls Out Condom Extravaganza for Sexy Holiday Businesswire
13-Feb-2024 Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Results Businesswire
13-Feb-2024 Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions Businesswire
12-Feb-2024 Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023 AccessWire
12-Feb-2024 AMLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Amylyx Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Businesswire
12-Feb-2024 Performance Health Partners Clinches Top Spot Again: Voted No. 1 in Healthcare Safety, Risk, and Compliance Software by KLAS Research AccessWire